Femasys Inc. Files Proxy Materials
Ticker: FEMY · Form: DEFA14A · Filed: Apr 28, 2025 · CIK: 1339005
| Field | Detail |
|---|---|
| Company | Femasys Inc (FEMY) |
| Form Type | DEFA14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing, corporate-governance
TL;DR
Femasys filed proxy docs, likely routine shareholder stuff. No fee paid.
AI Summary
Femasys Inc. filed a Definitive Additional Materials proxy statement on April 28, 2025. This filing is related to the company's proxy materials and does not appear to contain new proposals or significant financial updates, as indicated by the 'No fee required' status and the form type.
Why It Matters
This filing indicates that Femasys Inc. is providing additional information to shareholders regarding proxy matters, which is a standard part of corporate governance and shareholder communication.
Risk Assessment
Risk Level: low — The filing is a routine proxy statement, indicating standard corporate governance procedures rather than significant new risks or opportunities.
Key Players & Entities
- FEMASYS INC. (company) — Registrant
- BROADRIDGE CORPORATE ISSUER SOLUTIONS (company) — Proxy material distributor
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, specifically 'Definitive Additional Materials' for Femasys Inc.
When was this filing submitted?
The filing was submitted on April 28, 2025.
What is the company's primary business classification?
Femasys Inc. is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' with SIC code 3841.
Where is Femasys Inc. headquartered?
Femasys Inc. is located in Suwanee, Georgia.
Was there a fee required for this filing?
No, the filing indicates 'No fee required'.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 28, 2025 regarding FEMASYS INC (FEMY).